Video | January 8, 2021

What Opportunities Does Virtual Pitching Afford?

Source: Life Science Leader

Josh Brumm, CEO of Dyne Therapeutics, discusses some of the “pros” to pitching virtually. Keith Vendola, M.D, CSO and head of strategy at Rezolute, adds to the conversation by discussing the difficulty making a human connection via Zoom. This is a segment of a larger executive virtual roundtable (EVR) that also included Markus Warmuth, M.D., CEO of Monte Rosa Therapeutics on the topic of Pitching And Fundraising In The New Norm (full video here).